Login

Christoph Vilanek, CEO of Freenet AG, speaking at the 10th International Brand Colloquium in 2013. 00:10:00

Share On Facebook Share On Twitter

Christoph Vilanek is Chairman-Mgmt Board/CEO at freenet AG.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
The Last Honest Man: Frank Church's Legacy in Defending Democracy|James Risen, Professor,University of Maryland's Philip Merrill College of Journalism
00:10:00
Dieter Sand, CEO of Arlandastad Group: Insights from Penser Access by Carnegie | Dieter Sand, CEO, Arlandastad Group AB.
00:10:00
Alderan Resources: Advancing High-Grade Copper and Gold Projects in Argentina
00:10:00
Allbirds CEO Joey Zwillinger on Amazon's New Wool Shoe and Market Competition | Joey Zwillinger, CEO, Allbirds Inc.
00:10:00
AGCO CEO Discusses Grain Price Surge Amid Ukraine War | ERIC HANSOTIA - Chairman, President & CEO of AGCO Corp
00:10:00
CEO and Founder of Aritzia Shares His Journey with Bill Good | Brian Hill, CEO, Aritzia.
00:10:00
Pioneering Economic Resilience and Financial Opportunities | Dato’ Seri Cheah Cheng Hye, Co-Chairman , Value Partners .
00:10:00
Invests in companies where women hold leadership positions|Peggy Wallace,Managing Partner,Golden Seeds
00:10:00
From Chicken Wings to Red Zones: The Entrepreneurial Journey of Ted Farnsworth, CEO of Helios and Matheson Analytics
00:10:00
Greif's Sustainable Innovations: Today and Tomorrow | Ole Rosgaard - President and Chief Executive Officer of Greif, Inc.
00:10:00
ROCA Industry’s Strong First Semester Results and Market Outlook | Ionuț Bindea, CEO, ROCA Industry Holdingrock1 SA.
00:10:00
Timm Schneider ZignSec Pitch | CEO at ZignSec | Glenn Donald, CEO, ZignSec AB (publ)ZIGN:STO

© 2026 Nehu